Macular Degeneration Treatment Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the Macular Degeneration Treatment Market?
The escalating prevalence of retinal disorders is predicted to fuel the expansion of the macular degeneration treatment market. These disorders harm the critical tissue that manages how we perceive visual data, resulting in absent or distorted vision. For example, the American Academy of Ophthalmology predicts that by 2050, around 7.32 million individuals in the United States will suffer from primary open-angle glaucoma. This term encompasses a variety of eye diseases and is most prevalent in individuals between 70 to 79 years old (32%), women (50%), and Hispanics (50%). The most significant demographic group being Hispanic men. Therefore, the growing occurrence of retinal disorders is a key driver for the development of the macular degeneration treatment market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp
#What Long-Term Growth Rate is Expected for theMacular Degeneration Treatment Market Between 2025 and 2034?
Over the past few years, the market size for the treatment of macular degeneration has seen a swift expansion. The growth is projected to continue, rising from $11.05 billion in 2024 to an estimated $12.42 billion in 2025, which demonstrates a compound annual growth rate (CAGR) of 12.4%. Factors contributing to this increase during the historic period include an aging population, shifts in lifestyle, a scarcity of treatment alternatives, heightening awareness, and infrastructural advancements in the healthcare sector.
In the coming years, the market size for macular degeneration treatment is projected to experience significant growth. The market is estimated to reach a value of $19.06 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%. This growth during the forecast period is likely due to advancements in research, higher healthcare spending, increased incidence rates, personalized medicine strategies, and worldwide initiatives for vision health. Key trends anticipated during this period include emphasis on neuroprotection and regenerative therapies, the proliferation of telemedicine and remote patient monitoring, personalized medicine strategies, exploration of stem cell therapies, and patient-oriented initiatives for promoting awareness and education.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5799
What New Market Trends Are Reshaping theMacular Degeneration Treatment Market and Its Opportunities?
Top corporations in the macular degeneration treatment market are honing their focus on creating biosimilars for the treatment of age-related macular degeneration (AMD) with the intent of improving access to potent therapies. Biosimilars are essentially biological medical products that share a high degree of similarity to a pre-existing approved reference solution, but with no significant differences in safety, purity, or effectiveness. For example, in May 2024, Biocon Biologics Ltd, an India-based business, as well as Samsung Bioepis Co. Ltd, situated in South Korea, gained FDA approvals for their new biosimilars, Yesafili and Opuviz. These biosimilars hinder vascular endothelial growth factor (VEGF), a key player in the abnormal growth of blood vessels in the eye. With this interference, vision loss can be prevented in diseases like AMD and diabetic retinopathy. The FDA approved Yesafili and Opuviz after comparative studies revealed their efficacy and safety level were on par with Eylea. This approval process included vigorous evaluation of the biosimilars with respect to pharmacokinetics and immunogenicity.
Who Are the Leading Market Players Fueling Growth in the Macular Degeneration Treatment Market Trend?
Major companies operating in the macular degeneration treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Panoptica, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceuticals, Aerie Pharmaceuticals Inc., BioXcel Therapeutics Inc., Regenxbio Inc., Spark Therapeutics Inc., Alimera Sciences Inc., Applied Genetic Technologies Corp (AGTC), Cell Medica Ltd., Ophthotech Corporation, Adverum Biotechnologies Inc., Neurotech Pharmaceuticals Inc., 4D Molecular Therapeutics Inc., GenSight Biologics Inc.
Order Your Report Now For A Swift Delivery:
How is the Global Macular Degeneration Treatment Market Segemented?
The macular degeneration treatment market covered in this report is segmented –
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
3) By Route of Administration: Oral, Injectable, Other Route of Administration
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration
Subsegments:
1) By Early-Stage AMD: Nutritional Supplements, Lifestyle Modification Treatments
2) By Intermediate AMD: Anti-VEGF Injections, Photodynamic Therapy
3) By Late-Stage AMD: Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=5799&type=smp
Which Geographics are Influencing the Growth of the Macular Degeneration Treatment Market?
North America was the largest region in the macular degeneration treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment Market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Macular Degeneration Treatment Market 2025, By The Business Research Company:
Cutting Tool And Machine Tool Accessory Global Market Report 2024
Metal Valve Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/metal-valve-global-market-report
Stamped Metal Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stamped-metal-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
